The paramyxovirus fusion protein forms an extremely stable core trimer: Structural parallels to influenza virus haemagglutinin and HIV-1 gp41

Molecular Membrane Biology

Volumn 16, Issue 1, 1999, Pages 11-19

  Lamb, Robert A ^a,b   Joshi, Sangeeta Bagai ^b   Dutch, Rebecca Ellis ^b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fusion; Membranes; Paramyxovirus; Peptides; Viruses

Indexed keywords

GLYCOPROTEIN GP 41; HYBRID PROTEIN; INFLUENZA VIRUS HEMAGGLUTININ; LIPID; PEPTIDE; PROTEIN SUBUNIT;

ALPHA HELIX; CONFERENCE PAPER; CYTOPLASM; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; MEMBRANE FUSION; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; SIMIAN VIRUS; THERMOSTABILITY;

EID: 0032935886     PISSN: 09687688     EISSN: None     Source Type: Journal    
DOI: 10.1080/096876899294715     Document Type: Conference Paper

References (52)

1. Asano, K. and Asano, A., 1985, Why is a specific amino acid sequence of F glycoprotein required for the membrane fusion reaction between envelope of HVJ (Sendai virus) and target cell membranes? Biochemistry International, 10, 115-122.
2. Blacklow, S .C., Lu, M. and Kim, P. S., 1995, A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry, 34, 14956-14962.
3. Buckland, R., Malvoisin, E., Beauverger, P. and Wild, F., 1992, A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. Journal of General Virology, 73, 1703-1707.
4. Bullough, P. A., Hughson, F. M., Skehel, J. J. and Wiley, D. C., 1994, Structure of influenza haemagglutinin at the pH of membrane fusion. Nature, 371, 37-43.
5. Carr, C. M. and Kim, P. S., 1993, A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell, 73, 823-832.
6. Carr, C. M., Chaudhry, C. and Kim, P. S., 1997, Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proceedings of the National Academy of Sciences USA, 94, 14306-14313.
7. Chambers, P., Pringle, C. R. and Easton, A. J., 1990, Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. Journal of General Virology, 71, 3075-3080.
8. Chan, D. C., Fass, D., Berger, J. M. and Kim, P. S., 1997, Core structure of gp41 from the HIV envelope glycoprotein. Cell, 89, 263-273.
9. Chernomordik, L. V., Leikina, E., Frolov, V., Bronk, P. and Zimmerberg, J., 1997, An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids. Journal of Cell Biology, 136, 81-93.
10. Damico, R. L., Crane, J. and Bates, P., 1998, Receptor-triggered membrane association of a model retroviral glycoprotein. Proceedings of the National Academy of Sciences USA, 95, 2580-2585.
11. Fass, D. and Kim, P. S., 1995, Dissection of a retrovirus envelope protein reveals structure similarity to influenza hemagglutinin. Current Biology, 5, 1377-1383.
12. Fass, D., Harrison, S. C. and Kim, P. S., 1996a, Retrovirus envelope domain at 1.7Å resolution. Nature Structure Biology, 3, 465-469.
13. Fass, D., Harrison, S.C. and Kim, P.S., 1996b, Structure of Moloney murine virus envelope domain at 1.7Å resolution. Nature Structure Biology, 3, 465-469.
14. Ghosh, J. K., Ovadia, M. and Shai, Y., 1997, A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus. Biochemistry, 36, 15451-15462.
15. Hart, T. S., Kirsh, R., Ellens, H., Sweet, R. W., Lambert, D. M., Petteway, S. R., Leary, J. and Bugelski, P. J., 1991, Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proceedings of the National Academy of Sciences USA, 88, 2189-2193.
16. Hernandez, L. D., Hoffman, L. R., Wolsberg, T. G. and White, J. M., 1996, Virus-cell and cell-cell fusion. Annual Review of Cell Biology, 12, 627-661.
17. Hernandez, L. D., Peters, R. J., Delos, S. E., Young, J. A. T., Agard, D. A. and White, J. M., 1997, Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. Journal of Cell Biology, 139, 1455-1464.
18. Hughson, F. M., 1997, Enveloped viruses: a common mode of membrane fusion? Current Biology, 7, R565-R569.
19. Hunter, E., 1997, Viral entry and receptors. In Retroviruses, J. M. Coffin, S. H. Hughes and H. E. Varmus, eds (Cold Spring Harbor, NY: Cold Spring Harbor Press), pp. 71-119.
20. Jiang, S., Lin, K., Strick, N. and Neurath, A. R., 1993a, HIV-1 inhibition by a peptide [letter]. Nature, 365, 113.
21. Jiang, S., Lin, K., Strick, N and Neurath, A. R., 19935, Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41. Biochemistry Biophysics Research Communications, 195, 533-538.
22. Joshi, S. B., Dutch, R. E. and Lamb, R. A., 1998, A core timer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology, 248, 20-34.
23. Judice, J. K., Tom, J. Y. K., Huang, W., Wrin, T., Vennari, J., Petropoulos, C. J. and McDowell, R. S., 1997, Inhibition of HIV type 1 infectivity by constrained α-helical peptides: implications or the viral fusion mechanism. Proceedings of the National Academy of Sciences USA, 94, 13426-13430.
24. Klenk, H. -D. and Garten, W., 1994, Host cell proteases controlling virus pathogenicity. Trends in Microbiology, 2, 39-43.
25. Lamb, R. A., 1993, Paramyxovirus fusion: a hypothesis for changes. Virology, 197, 1-11.
26. Lamb, R. A. and Kolakofsky, D., 1996, Paramyxoviridae: the viruses and their replication. In Virology, 3rd Edn, B. N. Fields, D. M. Knipe and P. M. Howley, eds (New York: Raven Press), pp. 1177-1204.
27. Lambert, D. M., Barney, S., Lambert, A. L., Guthrine, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G. and Pettaway, S. R., Jr., 1996, Peptides form conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proceedings of the National Academy of Sciences USA, 93. 2186-2191.
28. Lu, M., Blacklow, S. C. and Kim, P. S., 1995, A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Structure Biology, 2, 1075-1082.
29. Moore, J. P., McKeating, J. A., Weiss, R. A. and Sattentau, Q. J., 1990, Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science, 250, 1130-1142.
30. Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E. and Blumenthal, R., 1998, Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. Journal of cell Biology, 140, 315-323.
31. Nehete, P. N., Arlinghaus, R. B. and Sastry, K. J., 1993, Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120. Journal of Virology, 67, 6841-6846.
32. Novick, S. L. and Hoekstra, D., 1988, Membrane penetration of Sendai virus glycoproteins during the early stage of fusion with liposomes as determined by hydrophobic affinity labeling. Proceedings of the National Academy of Sciences USA, 85, 7433-7437.
33. Paterson, R. G., Harris, T. J. R. and Lamb, R. A., 1984, Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Proceedings of the National Academy of Sciences USA, 81, 6706-6710.
34. Paterson, R. G., Hiebert, S. W. and Lamb, R. A., 1985, Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proceedings of the National Academy of Sciences USA, 82, 7520-7524.
35. Rapaport, D., Ovadia, M. and Shai, Y., 1995, A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO Journal, 14, 5524-5531.
36. Ruigrok, R. W. H., Martin, S. R., Wharton, S. A., Skehel, J. J., Bayley, P. M. and Wiley, D. C., 1986, Conformational changes in the hemagglutinin of influenza virus which accompany heat-induced fusion of virus with liposomes. Virology, 155, 484-497.
37. Russell, R., Paterson, R. G. and Lamb, R. A., 1994, Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion proteins. Virology, 199, 160-168.
38. Scheid, A. and Choppin, P. W., 1974, Identification of biological activities paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytilc cleavage of an inactive precursor protein of Sendai virus. Virology, 57, 475-490.
39. Sergel-German, T., McQuain, C. and Morrison, T., 1994, Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. Journal of Virology, 68, 7654-7658.
40. Slepushkin, V. A., Kornilaeva, G. V., Andreev, S., Sidorova, M. V., Petrukhina, A. O., Matsevich, G. R., Raduk, S. V., Grigoriev, V. B., Makarova, T. V. and Lukashov, V. V., 1993, Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein. Virology, 194, 294-301.
41. Storrs, R. W., Truckses, D. and Wemmer, D. E., 1992, Helix propagation in trifluoroethanol solutions. Biopolymers, 32, 1695-1702.
42. Tan, K., Liu, J. -H., Wang, J. -H., Shen, S. and Lu, M., 1997, Atomic structure of a thermostable subdomain of HIV-1 gp41. Proceedings of the National Academy of Sciences, 94, 12303-12308.
43. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J. and Wiley, D. C., 1997, Atomic structure of the ectodomain from HIV-1 gp41. Nature, 387, 426-430.
44. Wharton, S. A., Calder, L. J., Ruigrok, R. W. H., Skehel, J. J., Steinhauer, D. A. and Wiley, D. C., 1995, Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO Journal, 14, 240-246.
45. Wild, C., Dubay, J. W., Greenwell, T., Baird, T., Jr., Oas, T. G., McDanal, C., Hunter, E. and Matthews, T., 1994a, Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proceedings of the National Academy of Sciences USA, 91, 12676-12680.
46. Wild, C., Oas, T., McDanal, C., Bolognesi, D. and Matthews, T., 1992, A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proceedings of the National Academy of Sciences USA, 89, 10537-10541.
47. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B. and Matthews, T. J., 1994b, Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infections. Proceedings of the National Academy of Sciences USA, 91, 9770-9774.
48. Wiley, D. C. and Skehel, J. J., 1987, The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annual Review of Biochemistry, 56, 365-394.
49. Wilson, I. A., Skehel, J. J. and Wiley, D. C., 1981, Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature, 289, 366-375.
50. Yao, Q. and Compans, R. W., 1996, Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein inhibitors of virus infection. Virology, 223, are potent 103-112.
51. Young, J. K., Hicks, R. P., Wright, G. E. and Morrison, T. G., 1997, Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology, 238, 291-304.
52. Zhou, J., Dutch, R. E. and Lamb, R. A., 1997, Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity. Virology, 239, 327-339.